ADA 2018

In this Exclusive Interview transcript, Lisa Latts talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about applications of Watson AI for diabetes care and the benefits for healthcare providers and patients who have diabetes and are taking diabetes medications.

In this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about Watson AI and what it can offer to healthcare providers and patients who have diabetes and are taking diabetes medications.

In part 1 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the work done in partnership with the ADA regarding findings among patients with diabetes and their use of medications.

In part 2 of this Exclusive Interview, Lisa Latts explains the process behind the artificial intelligence Watson in a conversation with Diabetes in Control Publisher Steve Freed.

In part 3 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the personalization of medicine as the future of diabetes care.

In part 4 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the genesis of Watson and the work currently in the pipeline.

In part 5 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the findings from the cardiovascular study for use in Watson.

In part 6 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about her desire to make the healthcare system work more effectively and improve the practice of medicine.

In part 7, the conclusion of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the Watson tools available and how to access them.

Adam Brown, diagnosed with diabetes in 2001, serves as Senior Editor and columnist at diaTribe.org and Head of Diabetes Technology & Connected Care at Close Concerns. Adam writes an acclaimed column for diaTribe, Adam’s Corner, which has brought actionable diabetes tips to over 1 million people since 2013. Adam writes and speaks extensively about diabetes and chronic disease, and, at age 29, is recognized as a leading expert in diabetes technology. Adam graduated summa cum laude from the Wharton School of the University of Pennsylvania in 2011 as a Joseph Wharton and Benjamin Franklin Scholar.